“Today’s Research to Tomorrow’s Clinical Trials”
The CCF Research Symposium puts forth the belief that local research dialogue will impact global research collaboration. For the last few years, regional experts, advocates, survivors and trainees have shared research and continue to advance the treatment of childhood cancer. This collaboration benefits all involved in identifying cures for pediatric cancer.
This year’s keynote presenter was Catherine Bollard, M.D., MBChB, Director, Center for Cancer and Immunology Research, Cancer Research Institute, Children’s National Health System.
Please visit the 2018 Symposium Report page for highlights, photos, and videos capturing the day.
3rd Annual Symposium Schedule
8:30 a.m. – 9:00 a.m. Registration/Breakfast
9:00 a.m.-11:25 a.m. Session I: Neuroblastoma and other solid tumors
- Holly Meany, M.D., Children’s National, “Clinical Update on Neuroblastoma”
- Alisha Bartels, advocate/mother of John Eric, who lost battle with neuroblastoma
- Micah J. Maxwell, M.D., Ph.D., Johns Hopkins Medicine, “Glutamine metabolic inhibition synergizes with L-asparaginase in MYCN-driven pediatric solid tumors”
- Jeff Rubens, M.D., Johns Hopkins Medicine, “New approaches to consider for Atypical Teratoid Rhabdoid Tumors”
- Saravana Selvanathan, Ph.D., Georgetown Lombardi Comprehensive Cancer Center, “Role of ARID1A isoforms in Ewing sarcoma”
11:25 p.m. – 12:00 p.m. Lunch
12:00 p.m. – 1:25 p.m. Poster Session
1:25 p.m. – 2:30 p.m. Keynote
- Catherine Bollard M.D., MBChB, Director, Center for Cancer and Immunology Research, Children’s Research Institute, Children’s National
- Introduction by Jeffrey Toretsky, M.D., Chair, CCF Scientific Advisory Board, and Clinical Director for Pediatric Hematology at Georgetown Lombardi Comprehensive Cancer Center
2:40 p.m. – 4:55 p.m. Session II: Leukemia/Lymphoma
- Helkha Peredo-Pinto, M.D., Georgetown Lombardi Comprehensive Cancer Center, “Clinical Update on Leukemia”
- Kalani Looper, AML survivor
- Haneen Shalabi, D.O. (2017 NextGen Award Recipient), National Cancer Institute at the National Institutes of Health, “CAR-T Therapy Can Render Patients with ALL into Next Generation Sequencing-Negative Remission and Can be an Effective Bridge to Transplant”
- Haydar Çelik, Ph.D., Georgetown Lombardi Comprehensive Cancer Center, “CD99-mediated signaling in Ewing sarcoma”
- Kirsten Williams, M.D., Children’s National, “Safety and Efficacy of Multiple Tumor Antigen Specific T-Cells for the Treatment of High Risk Leukemia and Lymphoma After HCT”
4:55 p.m. – 5:30 p.m. Reception
Other reasons to attend:
- Hear presentations from area researchers in the Baltimore/Washington area about their latest work in pediatric oncology.
- Share experiences with others at the poster session and during the Q&A
- Become part of a community of oncologists, researchers, advocates, and others dedicated to finding better treatment and cures for pediatric cancer.
Thanks to a generous grant from The Kahlert Foundation, the symposium is free to all attendees. However, to ensure room capacity and food quantity, we request that you register in advance. You are able to register up to five colleagues.